封面
市場調查報告書
商品編碼
1197524

醫療電子市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Medical Electronics Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計在預測期內,醫療電子市場的複合年增長率為 10.9%。

COVID-19 最初影響了醫療電子市場。 大流行期間成像量的下降影響了前一階段的市場增長速度。 例如,2021 年 7 月發表在美國放射學會雜誌上的一篇論文報告稱,2020 年(第 1-16 週)的總成像量與上一年相比下降了 12.29%。 他們還報告說,COVID-19 後(第 10-16 週)顯示所有患者服務站點的成像量減少幅度更大 (28.10%)。 同一份文件還報告說,在 16 週時,動態成像減少了 88%,其中 MRI 減少了近 74%。 這種由大流行引起的銷量下降正在對流行病中的市場增長產生影響。 然而,在大流行期間,患者監測設備的需求顯著增加,因為它們使臨床醫生能夠進行非接觸式交流並跟蹤醫療狀況。 此外,X射線成像在COVID-19及相關疾病診斷和治療中的應用對大流行後期的市場增長產生了積極影響。 例如,2021 年 6 月發表在 BMC 肺醫學雜誌上的一篇論文證實了胸部 X 光片可用於 COVID-19 肺炎患者的診斷和隨訪。 因此,在後疫情階段,由於放鬆管制、恢復診療服務以及醫學影像設備的高滲透,對醫療電子的需求增加,有望真正恢復。

這是由於慢性病發病率和患病率上升以及老年人口增加以及診斷成像設備的使用範圍擴大等因素造成的。

癌症、神經系統疾病、心血管疾病和呼吸系統疾病等慢性病負擔日益加重是推動市場增長的關鍵因素。 例如,根據 IDF 發布的 2022 年統計數據,全球約有 5.37 億 20-79 歲的成年人患有糖尿病,這一數字在 2030 年和 2045 年上升到 6.43 億。預計到 2020 年將增加到 7.83 億。 因此,越來越多的糖尿病和肥胖患者增加了患其他慢性疾病(如冠狀動脈疾病、高血壓和中風)的風險,從而增加了對心髒病的早期檢測和定期監測的需求。 因此,對心髒病的早期檢測和定期監測的需求越來越大,預計這將在預測期內推動市場增長。

此外,根據阿爾茨海默氏症協會 2022 年報告中公佈的數據,德國有超過 150 萬人患有阿爾茨海默氏症,預計到 2050 年這一數字將翻一番。 這將增加對早期發現和了解與輕度認知障礙相關的大腦異常的神經病理學機制的需求。 預計這將進一步增加對 MRI 和 CET 掃描檢查的需求,推動市場增長。

衰老是各種分子和細胞損傷隨時間累積,導致身心能力逐漸下降,患病風險增加。 老年人的常見疾病包括背部和頸部疼痛、骨關節炎、慢性阻塞性肺病、心髒病和癌症。 例如,根據澳大利亞統計局2022年3月更新,2020-2021年澳大利亞心髒病患病率為4.0%,相當於約100萬人。 統計數據還顯示,在澳大利亞,心髒病隨著年齡的增長而增加,從 45-54 歲人群的 2.3% 增加到 75 歲及以上人群的 23.2%,其中男性受影響最大。 老年人更容易患心髒病,預計這將增加對診斷醫療電子設備的需求,這有望推動市場增長。

此外,預計在預測期內,增加產品發布和批准也將推動市場增長。 例如,2022 年 3 月,Rapid Response Revival 宣布推出首批使用先進技術的個人門診除顫器之一,旨在增加心臟驟停的倖存機率。CellAED 在英國上市。

此外,增加政府資金和增加企業開發先進產品的活動也促進了市場增長。 例如,2021 年 7 月,價值 31 億歐元(32.8 億美元)的新磁共振成像 (MRI) 掃描儀設施在萊斯特開業。 新設施將使研究人員的成像能力從目前每年 500 名心血管研究參與者增加到 1,500 名。 新的掃描儀設施由 BHF 提供的 100 萬歐元(110 萬美元)贈款資助。 該設施將由萊斯特醫院和萊斯特大學共同擁有,後者出資 210 萬歐元(220 萬美元)。

因此,由於上述因素,預計所研究的市場在預測期內將會增長。 然而,設備審批的嚴格規定和設備的高維護成本預計將在預測期內阻礙醫療電子市場的增長。

醫療電子市場趨勢

在市場細分方面,預計 MRI 細分市場在預測期內將佔據較大的市場份額

由於先進 MRI 系統的引入以及 MRI 系統在新興國家的滲透率不斷提高等因素,預計在預測期內,磁共振成像 (MRI) 領域將見證醫療電子市場的顯著增長。 許多新興國家人口稠密,醫療基礎設施發達。 在這些地區,除了老齡化社會的進展之外,由於癌症、肌肉骨骼疾病和神經系統疾病等疾病的負擔很大,預計未來 MRI 系統的採用將會增加。

技術先進系統的開發及其採用和產品發布的增加預計將增加這些系統在市場上的可用性,並在預測期內促進細分市場的增長。 例如,2021 年 2 月,Insitec 的 Exablate 4000(Exablate Neuro)平台獲得了巴西 HRA ANVISA 的市場批准。 據說該平台使用 MR 引導的聚焦超聲在沒有切口的情況下精確消融大腦深處的組織,從而能夠治療特發性震顫和以震顫為主的帕金森病。 同樣,2021 年 10 月,Esotee 將推出全身磁共振成像系統“Magnifico Open”,這是一種最先進的開放式 MRI 系統,不僅可以滿足臨床需求,還可以滿足運營和財務需求。

此外,專注於採用擴張、協作等各種關鍵戰略的公司的興起也有助於該細分市場的增長。 例如,2021 年 11 月,位於印度哈裡亞納邦的 NBRC 啟用了先進的 MRI 設備。 此外,2021 年 7 月,一個價值 31 億歐元(32.8 億美元)的新磁共振成像 (MRI) 掃描儀設施將在萊斯特啟用,研究人員的成像能力從目前的每年 500 人增加到 1,500 人。 新的掃描儀設施由 BHF 提供的 100 萬歐元(100 萬美元)贈款資助。

因此,由於上述因素(例如產品發布數量增加和企業活動增加),預計所研究的細分市場將在預測期內實現增長。

預計在預測期內北美將佔據很大的市場份額

北美將在預測期內主導市場,原因包括人口增長導致慢性病負擔不斷增加、醫療保健系統中先進技術的使用增加、完善的醫療保健基礎設施以及高昂的醫療保健成本. 預計。 預計在預測期內,對微創治療的需求不斷增長和醫療電子技術的進步也將推動市場增長。

慢性病患病率和負擔的增加是推動該地區醫療電子產品需求的一個關鍵因素。 例如,根據疾病預防控制中心發布的數據,2022 年 4 月,估計到 2040 年美國將有 3500 萬成年人患有關節炎。 因此,對提供關節和周圍組織詳細圖像並有助於早期發現症狀的醫療電子設備的需求預計將推動市場增長。 根據ACS公佈的2022年統計數據,2022年美國和新墨西哥州預計將分別新增超過190萬癌症患者和11030例新癌症患者。 根據加拿大癌症協會發布的2022年統計數據,預計2022年加拿大將診斷出約233,900例新癌症病例。 隨著癌症患者數量的增加,對 MRI 和 CT 掃描等有助於早期檢測體內腫瘤的醫療電子設備的需求也在增加。 預計這將在預測期內推動市場增長。

此外,企業產品開發活動的增加和產品發布的增加也促進了市場增長。 例如,2022 年 2 月,Esaote 的新型開放式全身 MRI 系統 Magnifico Open MRI 在美國獲得 FDA 批准。 同樣在 2021 年 7 月,美國食品和藥物管理局批准了兩種 Acurhythm 人工智能(AI)算法用於美敦力(Medtronic)的 LINQ II 插入式心臟監護儀(ICM)。

因此,由於人口中關節炎和癌症的高負擔以及企業活動增加等因素,預計該地區的研究市場將在預測期內增長。

醫療電子市場競爭對手分析

由於存在許多大型企業,醫療電子市場競爭激烈。 從市場份額的角度來看,一些主要參與者目前主導著市場。 一些主要參與者正在積極尋求與其他公司的收購和合資企業,以鞏固其在全球的市場地位。 目前主導市場的公司包括 Medtronics PLC、GE Healthcare、Koninklijke Philips NV、Siemens Healthcare GmbH 和 Fujifilm Corporation。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 老年人口增加
    • 增加成像設備的應用
  • 市場製約因素
    • 加強監管機構的監督
    • 高成本和維護
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分(基於價值的市場規模:百萬美元)

  • 按產品分類
    • 非侵入性產品
      • 核磁共振
      • X光
      • CT掃描
      • 超聲診斷設備
      • 核醫學成像系統
      • 心臟監測儀
      • 呼吸監測儀
      • 血流動力學監測儀
      • 多參數監護儀
      • 數字溫度計
      • 其他產品
    • 侵入性產品
      • 內窺鏡
      • 起搏器
      • 植入式心律轉復除顫器 (ICD)
      • 嵌入式循環記錄器
      • 脊髓刺激器
      • 其他侵入性產品
  • 通過申請
    • 診斷設備
    • 監控
    • 治療設備
  • 最終用戶
    • 醫院和診所
    • 門診手術中心
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Medtronic PLC
    • GE Healthcare
    • Koninklijke Philips NV
    • Siemens Healthcare GmbH
    • Fujifilm Corporation
    • McKesson Corporation
    • Olympus Corporation
    • Hologic Inc.
    • Dragerwerk AG & Co. KGaA
    • Getinge Inc.
    • Esaote SpA
    • Canon Medical Systems
    • Mindray Medical International Limited

第7章 市場機會與今後動向

簡介目錄
Product Code: 67992

The medical electronics market is expected to witness a CAGR of 10.9% during the forecast period.

COVID-19 impacted the medical electronics market initially. The decrease in imaging volumes during the pandemic affected the growth pace of the market in the preliminary phase. For instance, an article published in the Journal of the American College of Radiology in July 2021, reported that the total imaging volume in 2020 (weeks 1-16) declined by 12.29% as compared to the previous year. It also reported that post-COVID-19 (weeks 10-16) revealed a greater decrease (28.10%) in imaging volumes across all patient service locations. The same source also reported that an 88% decline was seen at week 16 in outpatient imaging, and MRI contributed to a nearly 74% decline. Such a decline in volumes due to the pandemic has impacted market growth amid the outbreak. However, the demand for patient monitoring devices greatly increased during the pandemic period as they allowed contactless communication and tracking of medical conditions by clinicians. Moreover, the application of x-ray imaging for the diagnosis and treatment of COVID-19 and associated diseases has positively impacted the market's growth in the latter phase of the pandemic. For instance, from an article published in BMC Pulmonary Medicine Journal, in June 2021, it has been observed that a chest x-ray was used to diagnose and follow up patients with COVID-19 pneumonia. Thus, with the relaxed restrictions, resumed diagnosis and treatment services, and the high adoption of medical imaging equipment, the demand for medical electronics has increased in the post-pandemic phase, and as per the analysis, the market is expected to regain its full potential in the next two to three years.

The factors such as the rising incidence and prevalence of chronic diseases coupled with the increasing geriatric population and the growing application of imaging devices.

The increasing burden of chronic diseases such as cancer, neurological diseases, cardiovascular diseases, respiratory diseases, and others are the key factor driving the market growth. For instance, according to the 2022 statistics published by the IDF, about 537 million adults aged between 20-79 were living with diabetes globally, and this number is projected to increase to 643 million and 783 million by 2030 and 2045, respectively. Thus, the higher number of diabetic and obese people increases the risk of developing other chronic diseases such as coronary artery disease, hypertension, and stroke, which increases the need for early detection as well as regular monitoring of the heart condition. This is anticipated to fuel market growth over the forecast period.

Additionally, as per data published in the Alzheimer's Association 2022 report, more than 1.5 million people in Germany were suffering from Alzheimer's disease, and this number is expected to double by 2050. This is anticipated to increase the need to early detect the brain abnormalities associated with mild cognitive impairment as well as understand the neuropathological mechanisms. This is further expected to fuel the demand for MRI and CET scan testing, thereby bolstering the market growth.

Aging results from accumulating a wide variety of molecular and cellular damage over time, leading to a gradual decrease in physical and mental capacity and a growing risk of disease. Common conditions in older age include back and neck pain and osteoarthritis, chronic obstructive pulmonary diseases, heart diseases, cancer, and others. For instance, according to the March 2022 update of the Australian Bureau of Statistics, the prevalence of heart disease in Australia was 4.0% in 2020-2021, which equates to about 1 million people. Also, as per the same source, in Australia, heart disease increased with age, from 2.3% of people aged 45-54 years through to 23.2% of people aged 75 years and over, with males being the most affected by it in the country. Since the older population is prone to the disease, it is expected to generate the need for medical electronics for diagnosis, thereby driving the market's growth.

Furthermore, rising product launches and approvals are also expected to increase market growth over the forecast period. For instance, in March 2022, Rapid Response Revival launched CellAED, one of the first personal, portable defibrillators that use sophisticated technology designed to improve the chances of surviving a sudden cardiac arrest, in the United Kingdom.

Moreover, the increasing government funding, as well as rising company activities for developing advanced products, are also contributing to the market growth. For instance, in July 2021, a new magnetic resonance imaging (MRI) scanner facility opened in Leicester, worth EUR 3.1 billion (USD 3.28 billion). This new facility increases the current imaging capacity of researchers from 500 cardiovascular research participants a year to 1,500. The new scanner facility has been funded by a EUR 1 million (USD 1.1 million) grant from the BHF. It will be jointly owned by Leicester's Hospitals, which has dedicated EUR 2.1 million (USD 2.2 million) to the facility, and the University of Leicester.

Therefore, owing to the aforementioned factors, the studied market is expected to grow over the forecast period. However, the strict regulations for device approval and the high cost of maintenance of the devices are expected to hinder the growth of the medical electronics market over the forecast period.

Medical Electronics Market Trends

MRI Segment Expected to Hold Significant Market Share in the Medical Electronics Market Over the Forecast Period

The magnetic resonance imaging (MRI) segment is expected to witness significant growth in the medical electronics market over the forecast period owing to factors such as the introduction of advanced MRI systems and the rising adoption of MRI systems in emerging markets. Most of the emerging economies are densely populated countries with developing healthcare infrastructures, and the adoption of MRI systems in these regions is expected to increase over the years due to the high burden of diseases such as cancer, musculoskeletal and neurological disorders, and others, coupled with the growth in the aging population.

The growing development of technologically advanced systems and their increasing adoption and product launches increase the availability of these systems in the market and are expected to increase the market segment growth over the forecast period. For instance, in February 2021, Insightec received market approval from the Brazilian HRA, ANVISA, for its Exablate 4000 (Exablate Neuro) platform, which uses MR-guided focused ultrasound to precisely ablate tissue deep within the brain without incisions and will enable treatment for essential tremor and tremor-dominant Parkinson's disease. Similarly, in October 2021, Esaote launched a total body magnetic resonance imaging system called Magnifico Open, which is an open MRI system with cutting-edge technology to satisfy not only clinical needs but also address operational and financial demands.

Furthermore, the rising company's focus on adopting various key strategies, such as expansion, collaborations, and others, is also contributing to the market segment's growth. For instance, in November 2021, a sophisticated MRI facility was launched at the NBRC in Haryana, India. Also, in July 2021, a new magnetic resonance imaging (MRI) scanner facility opened in Leicester for EUR 3.1 billion (USD 3.28 billion), which will increase the current imaging capacity of researchers from 500 cardiovascular research participants a year to 1500. The new scanner facility has been funded by a EUR 1 million (USD 1 million) grant from the BHF.

Therefore, owing to the aforementioned factors, such as the rising number of product launches and increasing company activities, the studied segment is expected to grow over the forecast period.

North America is Expected to Have the Significant Market Share Over the Forecast Period

North America is expected to dominate the market over the forecast period owing to factors such as the rising burden of chronic diseases among the population, the increasing use of advanced technology in healthcare systems, the presence of a well-established healthcare infrastructure, and high healthcare spending. In addition, the growing demand for minimally invasive therapies and rising technological advancements in medical electronics are also expected to increase market growth over the forecast period.

The increasing prevalence and burden of chronic diseases is the key factor driving the demand for medical electronics in the region. For instance, as per the data published by the CDC, in April 2022, an estimated 35 million adults in the United States were expected to suffer from arthritis by 2040. This is expected to increase the demand for medical electronics that provide detailed images of the joint and surrounding tissues that aid in the early detection of the condition, hence boosting the market growth. Also, as per the 2022 statistics published by the ACS, over 1.9 million new cancer cases and 11,030 new cancer cases are expected to be diagnosed in the United States and New Mexico, respectively, in 2022. Also, as per 2022 statistics published by the Canadian Cancer Society, about 233,900 new cancer cases are expected to be diagnosed in Canada in 2022. With the growing burden of cancer cases, the demand for medical electronics such as MRIs, CT scans, and others is increasing, which helps in the early detection of tumors in the body. This is anticipated to fuel market growth over the forecast period.

Furthermore, the rising company activities in developing products and increasing product launches are also contributing to market growth. For instance, in February 2022, the FDA approved Esaote's Magnifico Open MRI, a new open whole-body MRI system in the United States. Also, in July 2021, the USFDA approved Medtronic's two AccuRhythm artificial intelligence (AI) algorithms for use with the LINQ II insertable cardiac monitor (ICM).

Therefore, owing to factors such as the high burden of arthritis and cancer among the population as well as growing company activities in the region, the studied market is anticipated to grow over the forecast period.

Medical Electronics Market Competitor Analysis

The medical electronics market is competitive with the presence of a large number of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions across the world. Some companies currently dominating the market include Medtronics PLC, GE Healthcare, Koninklijke Philips NV, Siemens Healthcare GmbH, and Fujifilm Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Geriatric Population
    • 4.2.2 Rising Application of Imaging Devices
  • 4.3 Market Restraints
    • 4.3.1 Ramped up regulatory scrutiny
    • 4.3.2 High Cost and Maintenance
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Non-invasive Products
      • 5.1.1.1 MRI
      • 5.1.1.2 X-Ray
      • 5.1.1.3 CT Scan
      • 5.1.1.4 Ultrasound
      • 5.1.1.5 Nuclear Imaging Systems
      • 5.1.1.6 Cardiac Monitors
      • 5.1.1.7 Respiratory Monitors
      • 5.1.1.8 Hemodynamic Monitors
      • 5.1.1.9 Multipara Monitors
      • 5.1.1.10 Digital Thermometers
      • 5.1.1.11 Other Products
    • 5.1.2 Invasive Products
      • 5.1.2.1 Endoscopes
      • 5.1.2.2 Pacemakers
      • 5.1.2.3 Implantable Cardioverter Defibrillator (ICD)
      • 5.1.2.4 Implantable Loop Recorders
      • 5.1.2.5 Spinal Cord Stimulator
      • 5.1.2.6 Other Invasive Products
  • 5.2 By Application
    • 5.2.1 Diagnostics
    • 5.2.2 Monitoring
    • 5.2.3 Therapeutics
  • 5.3 By End User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic PLC
    • 6.1.2 GE Healthcare
    • 6.1.3 Koninklijke Philips NV
    • 6.1.4 Siemens Healthcare GmbH
    • 6.1.5 Fujifilm Corporation
    • 6.1.6 McKesson Corporation
    • 6.1.7 Olympus Corporation
    • 6.1.8 Hologic Inc.
    • 6.1.9 Dragerwerk AG & Co. KGaA
    • 6.1.10 Getinge Inc.
    • 6.1.11 Esaote SpA
    • 6.1.12 Canon Medical Systems
    • 6.1.13 Mindray Medical International Limited

7 MARKET OPPORTUNITIES AND FUTURE TRENDS